Blue Note leukaemia DTx gets FDA breakthrough tag
pharmaphorum
JANUARY 11, 2022
Last year, Biofourmis said its heart failure tool BiovitalsHF was the first DTx to be awarded breakthrough status by the FDA. The post Blue Note leukaemia DTx gets FDA breakthrough tag appeared first on. Breakthrough designations can speed up the development of new therapies, making them available to patients sooner.
64 
Let's personalize your content